Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
Go back to Tenet Healthcare (THC) PT Raised to $160 at Deutsche Bank
July 29, 2024 7:14 AM EDT
Mizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
July 26, 2024 1:55 PM EDT
Mizuho analyst Ann Hynes raised the price target on Tenet Healthcare (NYSE: THC) to $170.00 (from $145.00) while maintaining a Outperform rating.
The analyst comments "We are raising our estimates, and raising our price target on THC to $170 from $145. Highlights of the quarter include... More
July 24, 2024 4:47 PM EDT
Citi analyst Jason Cassorla raised the price target on Tenet Healthcare (NYSE: THC) to $171.00 (from $139.00) while maintaining a Buy rating.
The analyst comments "2Q24 EBITDA of $945M ($915 ex retro TX) was ahead of expectations, driven by strength in USPI rev/case, hospital volume... More
July 24, 2024 6:50 AM EDT
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $2.31, $0.41 better than the analyst estimate of $1.90. Revenue for the quarter came in at $5.1 billion versus the consensus estimate of $4.99 billion.
GUIDANCE:
Tenet Healthcare sees Q3 2024 EPS of $2.16-$2.58, versus the consensus of... More
